Physician

Pratibha Kirit Desai, MD

According to 2025 Medicare claims, Pratibha Desai, MD (NPI: 1861488454) practices hematology/oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is COMPREHENSIVE HEMATOLOGY ONCOLOGY LLC (NPI: 1144786906; TIN: 833031637) and primary practice location at 33709-2236. Desai is affiliated with the VitaSavings Florida (ACO ID: A5713), participating under the MSSP model.

Desai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 77,092 HCPCS/CPT codes, and received $1,044,269 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,809 prescription claims across 452 beneficiaries totaling $10,230,579 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 35 claims. Open Payments data shows 169 records totaling $68,448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $2,127,467 to $1,044,269. In contrast, Part D prescription costs have moved sharply higher in recent years, from $2,247,782 to $10,230,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	565	292,882	$2,127,467
2016	680	307,013	$2,511,607
2017	461	168,580	$1,570,420
2018	392	147,681	$1,178,750
2019	280	124,500	$963,637
2020	238	102,356	$938,111
2021	371	120,917	$1,650,480
2022	281	52,524	$1,089,099
2023	291	61,671	$868,470
2024	270	77,092	$1,044,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	369	1,949	$2,247,782
2016	330	1,663	$3,077,765
2017	335	1,810	$2,868,055
2018	384	1,945	$3,759,544
2019	390	2,166	$4,545,895
2020	413	2,233	$6,342,160
2021	572	2,930	$8,127,362
2022	499	2,751	$9,734,438
2023	486	2,708	$10,256,656
2024	452	2,809	$10,230,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	22	$45,789
2022	N/R	22	$47,611
2023	N/R	36	$54,629
2024	N/R	35	$57,089

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	164	309	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	91	156	$13
80053	Blood test, comprehensive group of blood chemicals	88	180	$10
36415	Insertion of needle into vein for collection of blood sample	203	885	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	198	885	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	77	1,911	$952,167
Jakafi	Ruxolitinib Phosphate	48	1,440	$772,604
Procrit	Epoetin Alfa	243	6,643	$729,699
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	68	1,001	$623,228
Calquence	Acalabrutinib Maleate	41	1,230	$545,237

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	12	$56,440
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	11	$400
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	12	$249

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	164	$4,674	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$63,774	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pratibha Kirit Desai, MD?

Tedicare shows public-source Medicare data for Pratibha Kirit Desai, MD (NPI 1861488454), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pratibha Kirit Desai, MD have ACO affiliation data?

Pratibha Kirit Desai, MD is shown with ACO affiliation data for VitaSavings Florida (MSSP, ACO ID A5713).

What billing organization is linked to Pratibha Kirit Desai, MD?

Pratibha Kirit Desai, MD is linked to COMPREHENSIVE HEMATOLOGY ONCOLOGY LLC (billing NPI 1144786906) in the available physician profile data.

Does Pratibha Kirit Desai, MD have Open Payments data?

Pratibha Kirit Desai, MD has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.